Skip to main content

Home/ Dr. Goodyear/ Group items matching ""opioid growth factor"" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Nathan Goodyear

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model - 0 views

ebm.rsmjournals.com/...1036.full

low dose naltrexone LND low dose naltrexone cancer cell proliferation opioid growth factor OGF

shared by Nathan Goodyear on 27 Nov 12 - No Cached
  • Nathan Goodyear on 27 Nov 12
     
    low-dose naltrexone (NLD) is shown to inhibit growth in vivo.  This is important as it has implications in cancer therapies.  This study found a greater benefit with LDN and exogenous opioid growth factor (OGF).
Nathan Goodyear

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model - 0 views

ebm.sagepub.com/...1036.short

LDN low dose naltrexone opioid growth factor cancer

shared by Nathan Goodyear on 08 Sep 14 - No Cached
  • Nathan Goodyear on 08 Sep 14
     
    LDN inhibits cell proliferation through increased opioid growth factor and receptor translation.
Nathan Goodyear

Opioid growth factor and the treatment of human pancreatic cancer: A review - 0 views

www.ncbi.nlm.nih.gov/...PMC3942827

peptides peptide therapy cancer

shared by Nathan Goodyear on 04 Jul 20 - No Cached
  • Nathan Goodyear on 04 Jul 20
     
    Review of Opioid Growth Factor inhibition of cancer growth via inhibition in cell cycle.
Nathan Goodyear

Low-dose naltrexone (LDN): Tricking the body to heal itself - 0 views

www.sciencedaily.com/...110902133047.htm

low dose naltrexone LND opioid growth factor OGF inflammation cancer low dose naltrexone opioid growth factor

shared by Nathan Goodyear on 27 Nov 12 - No Cached
  • Nathan Goodyear on 27 Nov 12
     
    synopsis of a previously posted article on LDN and OGF in the potential use in cancer.
Nathan Goodyear

Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer - Ian S Zagon, Nancy K Porterfield, Patricia J McLaughlin, 2013 - 0 views

journals.sagepub.com/...1535370213489492

peptide therapy cancer peptides TNBC breast cancer

shared by Nathan Goodyear on 05 Jul 20 - No Cached
  • Nathan Goodyear on 05 Jul 20
     
    Peptide therapy effective in inhibits proliferation in TNBC.
1 - 8 of 8
Showing 20▼ items per page